Skip to content

Clinical trials

Phase 2 Sarcoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2 Country / region: Netherlands Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20041
20051
20061
20071
20083
20101
20121
20151
20161
20171
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Hoffmann-La Roche3
Children's Oncology Group2
National Cancer Institute (NCI)2
The Netherlands Cancer Institute2
Actuate Therapeutics Inc.1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
Morphotek1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma20
Sarcoma, Synovial5
Leiomyosarcoma4
Rhabdomyosarcoma4
Fibrosarcoma3
Hemangiosarcoma3
Histiocytoma, Malignant Fibrous3
Neuroectodermal Tumors, Primitive, Peripheral3
Astrocytoma2
Breast Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.